CWM
ARKG icon

Circle Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Circle Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,281
Closed -$201K – 184
2021
Q4 		$201K Sell
3,281
-12,732
-80% -$880K 0.03% 191
2021
Q3 		$1.2M Buy
16,013
+1,897
+13% +$159K 0.17% 58
2021
Q2 		$1.31M Buy
+14,116
New +$1.2M 0.19% 60

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Circle Wealth Management's ARKG Position: Q1 2022 in Review

Circle Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 3,281 shares — an estimated $201K sold.

Circle Wealth Management first reported a position in ARKG in Q2 2021 and held it in 3 quarters. The position peaked at $1.31M in Q2 2021. 388 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Circle Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Circle Wealth Management sold 3,281 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $201K.
  • Circle Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 3 quarters.
  • Circle Wealth Management's ARK Genomic Revolution ETF position peaked at $1.31M in Q2 2021.
  • 388 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Circle Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.